Company news

Phibro Animal Health Corporation (NASDAQ:PAHC) news

Every Phibro Animal Health Corporation press release and news update in one place — announcements, filings coverage, and company updates for investors.

View Phibro Animal Health Corporation stock analysis →

Press releases & updates

Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2026 Results

August 19, 2026

Phibro Animal Health Corporation to Participate in Stifel Jaws & Paws Conference

May 21, 2026

Phibro Animal Health Corporation to Participate in Bank of America Securities Health Care Conference

May 7, 2026

Phibro Animal Health Corporation Launches Companywide Sustainable Solutions Platform; Introduces VERRATAIN Verified Sustainability Soluti...

May 6, 2026

Phibro Animal Health Corporation Launches Companywide Sustainable Solutions Platform; Introduces VERRATAIN™ Verified Sustainability Solut...

May 5, 2026

Phibro Animal Health Corporation Announces Regulatory Framework Change in Brazil for Antimicrobials

April 27, 2026

Phibro Animal Health Corporation to Participate in Bank of America 2026 Virtual Animal Health Summit

February 18, 2026

Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance

February 4, 2026

Phibro Animal Health Corporation Declares Quarterly Dividend

February 3, 2026

Phibro Animal Health Corporation to Host Webcast and Conference Call on Second Quarter Results

January 28, 2026

Phibro Animal Health Corporation Announces Leadership Transition

December 18, 2025

Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance

November 5, 2025

Phibro Animal Health Corporation Announces National Launch of Restoris™ Piezoelectric Dental Gel for Dogs

October 30, 2025

Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results

October 29, 2025

Phibro Animal Health Corporation Announces Licensing Agreement with Lighthouse Pharmaceuticals, Inc. for Innovative Periodontal Health As...

October 9, 2025

Phibro Animal Health Corporation to Participate at Morgan Stanley Annual Global Healthcare Conference

September 2, 2025

Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance

August 27, 2025

Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2025 Results

August 20, 2025

Phibro Animal Health Corporation to Participate at Stifel Jaws & Paws Conference

May 22, 2025

Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance

May 7, 2025

Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results

April 23, 2025

Phibro Animal Health Corporation to Participate at Barclays Annual Global Healthcare Conference

March 5, 2025

Phibro Animal Health Corporation to Participate at Bank of America 2025 Virtual Animal Health Summit

February 20, 2025

Phibro Animal Health Corporation Announces the Appointment of Joyce J. Lee to Its Board of Directors

January 23, 2025

Phibro Animal Health Corporation Completes Acquisition of Zoetis’ Medicated Feed Additive Product Portfolio and Certain Water-Soluble Pro...

October 31, 2024

Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2024 Results

August 14, 2024

Phibro Animal Health Corporation Releases Third Annual ESG Report: Connections that Advance Animal Health, Nutrition and Sustainability

June 5, 2024

Phibro Animal Health Corporation to Participate in Stifel Dental and Animal Health (Jaws & Paws) Conference

May 20, 2024

Zoetis to Sell Medicated Feed Additive Portfolio to Phibro Animal Health

April 28, 2024

Phibro Animal Health Corporation to Participate in Barclays Global Healthcare Conference

February 29, 2024

Phibro Animal Health Corporation to Participate in Bank of America 2024 Animal Health Summit

February 14, 2024

Phibro Animal Health Corporation Announces Chief Financial Officer Changes

February 6, 2024

Phibro Animal Health Corporation Reiterates Safety of Mecadox® and Intent to Defend its Use for Customers

November 7, 2023

Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2023 Results

July 31, 2023

Phibro Issues Second Environmental, Social and Governance Report

May 8, 2023

Phibro Animal Health Corporation Reports Third Quarter and Year-to-Date Results

May 3, 2023

Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Financial Results

April 13, 2023

Phibro Animal Health Corporation to Participate in Bank of America Securities 2023 Health Care Conference.

April 5, 2023

Phibro Animal Health Corporation to Participate in Bank of America 2023 Animal Health Summit

February 14, 2023

Phibro Animal Health Corporation Reports Second Quarter Results

February 8, 2023

Phibro Animal Health Corporation Announces the Appointment of Alejandro Bernal to Its Board of Directors and Declares Quarterly Dividend

February 6, 2023

Phibro Animal Health Corporation to Host Webcast and Conference Call on December 2022 Quarterly Financial Results

January 9, 2023

Phibro Animal Health Corporation Reports First Quarter Results, Revised Guidance

November 9, 2022

Phibro Animal Health Corporation to Host Webcast and Conference Call on September 2022 Quarterly Financial Results

October 3, 2022

Phibro Animal Health Corporation to Participate in Morgan Stanley Global Healthcare Conference

August 15, 2022

Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2022 Results

July 27, 2022

Phibro Animal Health Corporation and Rejuvenate Bio Announce Agreement to Develop Gene Therapy for Mitral Valve Disease in Canines

June 22, 2022

Phibro Issues Inaugural Environmental, Social and Governance Report

June 9, 2022

Phibro Animal Health Corporation Reports Third Quarter Results, Provides Revised Financial Guidance

May 4, 2022

Phibro Animal Health Corporation to Host Webcast and Conference Call on March 2022 Quarterly Financial Results

April 4, 2022

Older →